Unilateral Biportal Endoscopy Market Size & Trends

Unilateral Biportal Endoscopy Market Outlook (2022-2032)

[322 Pages Report] The global unilateral biportal endoscopy market size was valued at USD 750 million in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 6.5% from 2022 to 2032. Increasing demand for minimally invasive or key-hole surgeries for diagnostic and therapeutic purposes is expected to drive the overall growth.

Attribute	Details
Anticipated Base Year Value (2021)	US$ 750 million
Expected Market Value (2022)	US$ 798 million
Projected Forecast Value (2032)	US$ 1500 million
Global Growth Rate (2022 to 2032)	6.5% CAGR
Growth Rate of the North American Market (2022-2032)	6.7% CAGR
Expected Market Value of APAC (2032)	US$ 520 Million (Approx.)
U.K Market Expansion Rate (2022 to 2032)	6.8% CAGR
Key Companies Profiled	Endovision Co. Ltd. Karl Storz Smith & Nephew Stryker Corporation CONMED Corporation Maxer Endoscopy GmbH Joimax GmbH Richard Wolf Jiangsu Bonss Medical Technology Co. Ltd. Kinetix Lifesciences

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Key Factors Propelling the Unilateral Biportal Endoscopy Market Growth?

Advancements in the field of robotic surgery and visually advanced endoscopic procedures are expected to drive the demand for spinal endoscopic procedures. For instance, in March 2018, Auris Health, Inc. received FDA approval for its new robotic endoscopy system, Monarch Platform. In addition, the growing awareness levels of the benefits of these procedures such as reduced hospitalization, shortened operating time, minimal collateral tissue damage, and quicker recovery are boosting demand and contributing to market development. The emergence of advanced visualization technologies is complementing the growing demand for minimally invasive surgeries and is expected to positively influence the market for unilateral biportal endoscopy over the forthcoming years.

Some of these innovations are advanced image-guided technology, flexible radiolucent spinal implants, 3D printing of disc tissue, and bone fusion. The use of computer-assisted image guidance for spine localization is constantly evolving and is delivering real-time image datasets. Moreover, these advancements focus on the development of lesser noninvasive surgical techniques, preservation of motion in the operated spinal segment, minimum postoperative pain and complications, and reduction in recovery time.

Moreover, the growing number of healthcare facilities such as hospitals, ambulatory surgery centers, and specialty clinics is anticipated to boost the demand for unilateral biportal endoscopies over the forecast period. Furthermore, numerous healthcare professionally-owned and managed ambulatory surgery centers are gaining popularity with endoscopists carrying out minimally invasive surgeries in these outpatient settings.

For instance, in Europe, the U.K. had the highest number of hospitals, accounting for 3,186 in 2018 and this number is expected to reach 10,027 hospitals by 2025, growing at a CAGR of 18.0%. Furthermore, countries such as Brazil and South Africa are expected to register a significant increase in the number of hospitals with a CAGR of 10.1% and 11.8%, respectively.

Unilateral Biportal Endoscopy Market

What are the Major Trends in the Global Unilateral Biportal Endoscopy Market?

There has been a large-scale adoption of endoscopes and continuous technical evolution across the globe, backed by the development of advanced products that can be utilized in all healthcare units.

For instance, in February 2019, PENTAX Medical, which is a subsidiary of HOYA Corporation, introduced its argon plasma coagulation (APC) and integrated electrosurgical platforms, ENDO PLUS and ENDO ARC, which address coagulation concerns and offer electrosurgical capabilities. Such high-tech progress by endoscope market players has become a key cause behind the increasing popularity of new-generation endoscopes among healthcare specialists.

The mounting cases of chronic illnesses, such as cardiovascular diseases (CVDs), respiratory diseases, and cancer, will propel the demand for advanced endoscopy equipment in the nearby future.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What Challenges are in Store for Filter Unilateral Biportal Endoscopy Sales?

The dearth of trained physicians and endoscopists Acts as a Prominent Market Restraint. There is a substantial shortage of endoscopy physicians and surgeons across the globe. This shortage of trained professionals in endoscopy is also likely to be observed in the Asia Pacific, Latin America, and Europe (excluding the UK, where training has been provided for nurse endoscopists for the last decade by the United Kingdom Central Council for Nursing, Midwifery, and Health).

Skilled specialists are needed to efficiently conduct endoscopy procedures for averting the spread of infections in endoscopy facilities. The dearth of skilled endoscopy physicians and nurses in key regions is anticipated to destructively impact several endoscopy procedures carried out per year globally. A few market players, such as Olympus, have manufactured training centers to overcome this concern. In Asia alone, the company has 22 training centers for endoscopy. Such projects will enhance mindfulness about the latest technological progressions in the field of endoscopy, as well as increase the number of trained endoscopy professionals.

Country-wise Analysis

How Opportunistic are Growth Prospects across the North America Market?

North America dominated the market for unilateral biportal endoscopy and accounted for the largest revenue share of 42.4% in 2021, owing to factors such as developed and evolving healthcare infrastructure, growing geriatric population and enlarged prevalence of chronic diseases like cancer, widespread adoption of advanced technologies, presence of key players, and increase in awareness about advantages of minimally invasive surgeries.

Moreover, promising reimbursement policies for endoscopic procedures in the United States, and hefty investments by hospitals to purchase advanced endoscopic equipment is pushing the growth of the Unilateral Biportal Endoscopy market in the region.

A recently published report by Future Market Insights reveals that the North American Unilateral Biportal Endoscopy market is projected to expand to US$ 720 Million by 2032 from US$ 350 Million in 2021, following a Y-o-Y growth rate of 6.7% throughout the projection period.

Why are Unilateral Biportal Endoscopy Providers Venturing into the Asia Pacific?

The Asia Pacific is anticipated to register the fastest growth during the forecast period. Developing healthcare infrastructure and facilities, increased healthcare expenditures, and expansion of renowned players are propelling the unilateral biportal endoscopy market. In addition, infrastructure investments, regional expansion, economic development, and a highly-skilled workforce.

Moreover, companies are devising entry strategies and mergers and acquisitions to cater to the Asia Pacific endoscopy market. Besides, the APAC market growth is attributed to the augmented desire for the usage of endoscopes for treatment and diagnostics and technical improvements leading to better applications.

Furthermore, the market growth is anticipated to be driven by aspects such as the soaring number of hospitals, enlarged patient demand for less invasive procedures, technological developments, and an upsurge in the geriatric population in the region. Additionally, there is an increment in the usage of alternative endoscopic equipment and increased adoption and knowledge of therapy and diagnosis.

Future market insight’s recent analytical report summarizes that the APAC unilateral bi portal endoscopy market is estimated to reach US$ 520 Million, following a 6.5% CAGR throughout the forecast period.

Country-wise Value CAGRs for Unilateral Biportal Endoscopy (2022-2032)

USA	6.7%
UK	6.8%
China	6.5%
Japan	6.7%
South Korea	6.7%

Category-wise Insights

By Product Type, Which Segment Gained the Highest Traction in the Global Unilateral Biportal Endoscopy Market?

In 2021, the reusable product segment accounted for the largest revenue share of 95%. The traditional practice of using reusable products by surgeons and endoscopists is due to its recoverability rate and categorization based on exposure to infection risk. On the other hand, the single-use product segment is anticipated to register the fastest growth during the forecast period owing to the increasing prevalence of hospital-acquired infections caused by the use of reusable and uncleaned products.

As per reports, the transformation to single-use products has resulted in the U.S. endoscopic market growing tenfold over the past decade. Increasing usage of single-use endoscopes due to the low cost of maintenance, cleaning, and storage is propelling the product demand. For instance, in July 2019, Integrated Endoscopy received the U.S. FDA clearance for its NUVIS, a single-use, economical arthroscope.

By Application, which Unilateral Biportal Endoscopy is expected to Dominate?

In 2021, the decompression application segment accounted for the largest revenue share of 40%. Non-invasive nature and quicker recovery are some of the benefits of this procedure and are expected to boost the segment. The decompression procedure enables direct anatomical visualization and minimizes collateral tissue damage.

Additionally, decompression procedures have proven to have more favorable clinical outcomes when compared to conventional methods. per an Asian Spine Journal report published in April 2019, a study conducted to record clinical outcomes in 105 patients with spinal stenosis undergoing bilateral endoscopic surgeries and interlaminar decompression stated ODI improved from 67.4±11.5 to 22.9±12.4.

Furthermore, the decompression application segment is anticipated to register the fastest growth during the forecast period owing to benefits such as minimized collateral tissue damage, faster and assured recovery, small incision, and minimal blood loss. Furthermore, degenerative lumbar canal stenosis is the highest revenue-generating indication for decompression procedures since it prevents paraspinal muscle atrophy, reduced muscle dissection, and retraction when compared to conventional open surgical methods.

Competitive Landscape

Prominent Unilateral Biportal Endoscopy providers are reliant on partnerships, collaborations, acquisitions, and new software launches to stay afloat in the global market. Constant innovations to ensure a seamless client-customer relationship are the main focus of prominent market players.

In May 2022, Boston Scientific Corporation announced the worldwide commercial availability of its SpyGlass™ Direct Visualization System for single-operator duodenoscope assisted cholangiopancreatoscopy (SODAC) or visual examination of the bile ducts.
In Jan 2022, Stryker announced completed the acquisition of all of the issued and outstanding shares of common stock of Vocera Communications, Inc. for $79.25 per share, or a total equity value of approximately $2.97 billion and a total enterprise value of approximately $3.09 billion.
In May 2022, DLA Piper advised CONMED Corporation in its agreement to acquire privately-held In2Bones Global, Inc. (In2Bones), on a cash-free, debt-free basis, for cash consideration of US$145 million at closing. The deal also includes an additional US$110 million in growth-based earnout payments over four years

Key Segments Covered in the Unilateral Biportal Endoscopy Industry Survey

Unilateral Biportal Endoscopy by Product Outlook:

Reusable Unilateral Biportal Endoscopy
Single-use Unilateral Biportal Endoscopy

Unilateral Biportal Endoscopy by Application:

Unilateral Biportal Endoscopy for Decompression
Unilateral Biportal Endoscopy for Lumbar Central Canal Stenosis
Unilateral Biportal Endoscopy for Degenerative Lumbar Canal Stenosis
Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis
Unilateral Biportal Endoscopy for Deherniation
Unilateral Biportal Endoscopy for Spinal Stabilization
Others

Unilateral Biportal Endoscopy by End-user:

Unilateral Biportal Endoscopy in Hospitals
Unilateral Biportal Endoscopy in Ambulatory Surgery Centers/Clinics
Other end-users

Unilateral Biportal Endoscopy by Region:

North America Unilateral Biportal Endoscopy Market
Latin America Unilateral Biportal Endoscopy Market
Europe Unilateral Biportal Endoscopy Market
Asia Pacific Unilateral Biportal Endoscopy Market
The Middle East & Africa Unilateral Biportal Endoscopy Market

Frequently Asked Questions

What was the market worth for Unilateral Biportal Endoscopy in 2021?

As of 2021, Future Market Insights estimated the Unilateral Biportal Endoscopy market to have reached US$ 750 Million.

What is the expected worth of the Unilateral Biportal Endoscopy industry in 2022?

By 2022, Future Market Insights expected demand for Unilateral Biportal Endoscopy to reach US$ 798 Million.

At what rate did the Unilateral Biportal Endoscopy market flourish from 2015-to 2021?

From 2015-to 2021, the Unilateral Biportal Endoscopy market grew at a 6.3% value CAGR.

What is the expected forecast CAGR for Unilateral Biportal Endoscopy from 2022-to 2032?

From 2022-to 2032, Unilateral Biportal Endoscopy demand is likely to surge at a 6.5% CAGR.

At what value will the market for Unilateral Biportal Endoscopy close in 2032?

By 2032, the market for Unilateral Biportal Endoscopy is likely to be valued at US$ 1500 Million.

What is the expected market value for the North America Unilateral Biportal Endoscopy market?

By 2032, Future Market Insights expects the U.S market for Unilateral Biportal Endoscopy to reach US$ 720 Million.

How opportunistic is the APAC market for Unilateral Biportal Endoscopy?

APAC is expected to register a 6.5% CAGR in the Unilateral Biportal Endoscopy industry.

What are the expected growth rates for the South Korean and Japanese markets?

South Korea and Japan are expected to document CAGRs worth 6.7% and 6.8% respectively in the Unilateral Biportal Endoscopy market.

Which Type will account for the maximum Unilateral Biportal Endoscopy revenue?

Reusable Unilateral Biportal Endoscopy will be maximum, expanding at a 6.7% CAGR.

By Application, which category is likely to remain top-selling until 2032?

Decompression Biportal Endoscopy for the medium & small segment will remain most preferred, expanding at a CAGR of 7% until 2032.

Table of Content

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2017-2021
    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2022-2032
        5.3.1. Reusable
        5.3.2. Single Use
    5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021
    5.5. Absolute $ Opportunity Analysis By Product, 2022-2032
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
        6.3.1. Decompression
        6.3.2. Lumbar Central Canal Stenosis
        6.3.3. Degenerative Lumbar Canal Stenosis
        6.3.4. Lumbar Spinal Stenosis
        6.3.5. Deherniation
        6.3.6. Spinal Stabilization
        6.3.7. Other Applications
    6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
    6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End-user
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Mn) Analysis By End-user, 2017-2021
    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-user, 2022-2032
        7.3.1. Hospitals
        7.3.2. Ambulatory Surgery Centers/Clinics
        7.3.3. Other End-users
    7.4. Y-o-Y Growth Trend Analysis By End-user, 2017-2021
    7.5. Absolute $ Opportunity Analysis By End-user, 2022-2032
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
    8.1. Introduction
    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
        8.3.1. North America
        8.3.2. Latin America
        8.3.3. Europe
        8.3.4. Asia Pacific
        8.3.5. MEA
    8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        9.2.1. By Country
            9.2.1.1. U.K.
            9.2.1.2. Canada
        9.2.2. By Product
        9.2.3. By Application
        9.2.4. By End-user
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Product
        9.3.3. By Application
        9.3.4. By End-user
    9.4. Key Takeaways
10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        10.2.1. By Country
            10.2.1.1. Brazil
            10.2.1.2. Mexico
            10.2.1.3. Rest of Latin America
        10.2.2. By Product
        10.2.3. By Application
        10.2.4. By End-user
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product
        10.3.3. By Application
        10.3.4. By End-user
    10.4. Key Takeaways
11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        11.2.1. By Country
            11.2.1.1. Germany
            11.2.1.2. U.K.
            11.2.1.3. France
            11.2.1.4. Spain
            11.2.1.5. Italy
            11.2.1.6. Rest of Europe
        11.2.2. By Product
        11.2.3. By Application
        11.2.4. By End-user
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product
        11.3.3. By Application
        11.3.4. By End-user
    11.4. Key Takeaways
12. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        12.2.1. By Country
            12.2.1.1. China
            12.2.1.2. Japan
            12.2.1.3. South Korea
            12.2.1.4. Malaysia
            12.2.1.5. Singapore
            12.2.1.6. Australia
            12.2.1.7. Rest of Asia Pacific
        12.2.2. By Product
        12.2.3. By Application
        12.2.4. By End-user
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product
        12.3.3. By Application
        12.3.4. By End-user
    12.4. Key Takeaways
13. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        13.2.1. By Country
            13.2.1.1. GCC Countries
            13.2.1.2. South Africa
            13.2.1.3. Israel
            13.2.1.4. Rest of MEA
        13.2.2. By Product
        13.2.3. By Application
        13.2.4. By End-user
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product
        13.3.3. By Application
        13.3.4. By End-user
    13.4. Key Takeaways
14. Key Countries Market Analysis
    14.1. U.K.
        14.1.1. Pricing Analysis
        14.1.2. Market Share Analysis, 2021
            14.1.2.1. By Product
            14.1.2.2. By Application
            14.1.2.3. By End-user
    14.2. Canada
        14.2.1. Pricing Analysis
        14.2.2. Market Share Analysis, 2021
            14.2.2.1. By Product
            14.2.2.2. By Application
            14.2.2.3. By End-user
    14.3. Brazil
        14.3.1. Pricing Analysis
        14.3.2. Market Share Analysis, 2021
            14.3.2.1. By Product
            14.3.2.2. By Application
            14.3.2.3. By End-user
    14.4. Mexico
        14.4.1. Pricing Analysis
        14.4.2. Market Share Analysis, 2021
            14.4.2.1. By Product
            14.4.2.2. By Application
            14.4.2.3. By End-user
    14.5. Rest of Latin America
        14.5.1. Pricing Analysis
        14.5.2. Market Share Analysis, 2021
            14.5.2.1. By Product
            14.5.2.2. By Application
            14.5.2.3. By End-user
    14.6. Germany
        14.6.1. Pricing Analysis
        14.6.2. Market Share Analysis, 2021
            14.6.2.1. By Product
            14.6.2.2. By Application
            14.6.2.3. By End-user
    14.7. U.K.
        14.7.1. Pricing Analysis
        14.7.2. Market Share Analysis, 2021
            14.7.2.1. By Product
            14.7.2.2. By Application
            14.7.2.3. By End-user
    14.8. France
        14.8.1. Pricing Analysis
        14.8.2. Market Share Analysis, 2021
            14.8.2.1. By Product
            14.8.2.2. By Application
            14.8.2.3. By End-user
    14.9. Spain
        14.9.1. Pricing Analysis
        14.9.2. Market Share Analysis, 2021
            14.9.2.1. By Product
            14.9.2.2. By Application
            14.9.2.3. By End-user
    14.10. Italy
        14.10.1. Pricing Analysis
        14.10.2. Market Share Analysis, 2021
            14.10.2.1. By Product
            14.10.2.2. By Application
            14.10.2.3. By End-user
    14.11. Rest of Europe
        14.11.1. Pricing Analysis
        14.11.2. Market Share Analysis, 2021
            14.11.2.1. By Product
            14.11.2.2. By Application
            14.11.2.3. By End-user
    14.12. China
        14.12.1. Pricing Analysis
        14.12.2. Market Share Analysis, 2021
            14.12.2.1. By Product
            14.12.2.2. By Application
            14.12.2.3. By End-user
    14.13. Japan
        14.13.1. Pricing Analysis
        14.13.2. Market Share Analysis, 2021
            14.13.2.1. By Product
            14.13.2.2. By Application
            14.13.2.3. By End-user
    14.14. South Korea
        14.14.1. Pricing Analysis
        14.14.2. Market Share Analysis, 2021
            14.14.2.1. By Product
            14.14.2.2. By Application
            14.14.2.3. By End-user
    14.15. Malaysia
        14.15.1. Pricing Analysis
        14.15.2. Market Share Analysis, 2021
            14.15.2.1. By Product
            14.15.2.2. By Application
            14.15.2.3. By End-user
    14.16. Singapore
        14.16.1. Pricing Analysis
        14.16.2. Market Share Analysis, 2021
            14.16.2.1. By Product
            14.16.2.2. By Application
            14.16.2.3. By End-user
    14.17. Australia
        14.17.1. Pricing Analysis
        14.17.2. Market Share Analysis, 2021
            14.17.2.1. By Product
            14.17.2.2. By Application
            14.17.2.3. By End-user
    14.18. Rest of Asia Pacific
        14.18.1. Pricing Analysis
        14.18.2. Market Share Analysis, 2021
            14.18.2.1. By Product
            14.18.2.2. By Application
            14.18.2.3. By End-user
    14.19. GCC Countries
        14.19.1. Pricing Analysis
        14.19.2. Market Share Analysis, 2021
            14.19.2.1. By Product
            14.19.2.2. By Application
            14.19.2.3. By End-user
    14.20. South Africa
        14.20.1. Pricing Analysis
        14.20.2. Market Share Analysis, 2021
            14.20.2.1. By Product
            14.20.2.2. By Application
            14.20.2.3. By End-user
    14.21. Israel
        14.21.1. Pricing Analysis
        14.21.2. Market Share Analysis, 2021
            14.21.2.1. By Product
            14.21.2.2. By Application
            14.21.2.3. By End-user
    14.22. Rest of MEA
        14.22.1. Pricing Analysis
        14.22.2. Market Share Analysis, 2021
            14.22.2.1. By Product
            14.22.2.2. By Application
            14.22.2.3. By End-user
15. Market Structure Analysis
    15.1. Competition Dashboard
    15.2. Competition Benchmarking
    15.3. Market Share Analysis of Top Players
        15.3.1. By Regional
        15.3.2. By Product
        15.3.3. By Application
        15.3.4. By End-user
16. Competition Analysis
    16.1. Competition Deep Dive
        16.1.1. Endovision Co Ltd
            16.1.1.1. Overview
            16.1.1.2. Product Portfolio
            16.1.1.3. Profitability by Market Segments
            16.1.1.4. Sales Footprint
            16.1.1.5. Strategy Overview
                16.1.1.5.1. Marketing Strategy
        16.1.2. Karl Storz
            16.1.2.1. Overview
            16.1.2.2. Product Portfolio
            16.1.2.3. Profitability by Market Segments
            16.1.2.4. Sales Footprint
            16.1.2.5. Strategy Overview
                16.1.2.5.1. Marketing Strategy
        16.1.3. Smith & Nephew
            16.1.3.1. Overview
            16.1.3.2. Product Portfolio
            16.1.3.3. Profitability by Market Segments
            16.1.3.4. Sales Footprint
            16.1.3.5. Strategy Overview
                16.1.3.5.1. Marketing Strategy
        16.1.4. Stryker Corporation
            16.1.4.1. Overview
            16.1.4.2. Product Portfolio
            16.1.4.3. Profitability by Market Segments
            16.1.4.4. Sales Footprint
            16.1.4.5. Strategy Overview
                16.1.4.5.1. Marketing Strategy
        16.1.5. Conmed Corporation
            16.1.5.1. Overview
            16.1.5.2. Product Portfolio
            16.1.5.3. Profitability by Market Segments
            16.1.5.4. Sales Footprint
            16.1.5.5. Strategy Overview
                16.1.5.5.1. Marketing Strategy
        16.1.6. Joimax Gmbh
            16.1.6.1. Overview
            16.1.6.2. Product Portfolio
            16.1.6.3. Profitability by Market Segments
            16.1.6.4. Sales Footprint
            16.1.6.5. Strategy Overview
                16.1.6.5.1. Marketing Strategy
        16.1.7. Richard Wolf
            16.1.7.1. Overview
            16.1.7.2. Product Portfolio
            16.1.7.3. Profitability by Market Segments
            16.1.7.4. Sales Footprint
            16.1.7.5. Strategy Overview
                16.1.7.5.1. Marketing Strategy
        16.1.8. Jiangsu Bonss Medical Technology Co. Ltd.
            16.1.8.1. Overview
            16.1.8.2. Product Portfolio
            16.1.8.3. Profitability by Market Segments
            16.1.8.4. Sales Footprint
            16.1.8.5. Strategy Overview
                16.1.8.5.1. Marketing Strategy
        16.1.9. Kinetix Lifesciences
            16.1.9.1. Overview
            16.1.9.2. Product Portfolio
            16.1.9.3. Profitability by Market Segments
            16.1.9.4. Sales Footprint
            16.1.9.5. Strategy Overview
                16.1.9.5.1. Marketing Strategy
        16.1.10. Maxer Endoscopy Gmbh
            16.1.10.1. Overview
            16.1.10.2. Product Portfolio
            16.1.10.3. Profitability by Market Segments
            16.1.10.4. Sales Footprint
            16.1.10.5. Strategy Overview
                16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology